News

News

Media Contact

    • 14 July 2017
    • Rosen Comments on FDA User Fee Legislation

    • In Modern Healthcare’s article, “House Passes Bipartisan FDA User Fee Bill,” Partner David Rosen discussed the impact of new legislation passed in the House of Representatives that reauthorizes the FDA’s ability to collect user fees from drug and device makers.
    • 22 September 2016
    • Rosen Quoted on FDA Requirements for Drug Shelf Life

    • Partner David Rosen was quoted in a Modern Healthcare article, “Extending EpiPen Shelf Life Could be a Relief for Patients, Costly for Mylan,” on September 22, 2016.
    • 24 October 2016
    • Rosen Quoted on Obstacles to Generic EpiPen

    • Partner David Rosen participated in a question and answer session with Reuter’s Westlaw, “Q&A: Foley & Lardner’s David Rosen on Obstacles to Generic EpiPen,” on October 24, 2106.
    Filters applied:
    Search phrase entered: